Status epilepticus is one of those “don’t-miss” neurology emergencies that shows up everywhere—from ICU vignettes to Step 1 pharm questions about GABA-A. If you can define it precisely, recognize subtle presentations (especially nonconvulsive status), and run the treatment algorithm without hesitating, you’ll pick up easy points and—more importantly—learn a real-life lifesaving workflow.
What is Status Epilepticus? (Definition + Step-Friendly Timing)
Status epilepticus (SE) = continuous seizure activity or recurrent seizures without return to baseline in between.
Modern operational definition (what matters clinically)
- Convulsive SE: seizure lasting minutes or recurrent seizures without regaining consciousness.
- Nonconvulsive SE: altered mental status with ongoing electrographic seizures; often considered persistent minutes, but in practice: suspect early and confirm with EEG.
Classic definition (still tested)
- Seizure activity minutes or repeated seizures without return to baseline.
Why the newer -minute cut-off? Because after ~ minutes, seizures are less likely to stop spontaneously and neuronal injury risk rises.
High-yield Step phrasing:
“Generalized tonic-clonic seizure lasting 7 minutes” = status epilepticus until proven otherwise.
Why Status Epilepticus Becomes Self-Sustaining (Pathophysiology)
Core mechanism: shifting receptor biology during ongoing seizures
As seizure activity persists:
- GABA-A receptors internalize → benzodiazepines become less effective over time
- NMDA receptor activity increases → excitotoxicity
- Metabolic demand skyrockets → hypoxia, lactic acidosis, hyperthermia, rhabdomyolysis
- Autonomic surge → tachycardia, hypertension early; hypotension later (especially after sedation)
Cellular injury (Step 1 angle)
- Excess glutamate → increased intracellular → neuronal death
- Hippocampal vulnerability is a classic association in prolonged seizures.
Key takeaway: Treat early—the first few minutes are the “benzodiazepine window.”
Etiologies & High-Yield Associations (Most Common Causes)
Think: breakthrough seizure in epilepsy, medication/nonadherence, metabolic, toxic, CNS catastrophe.
Common triggers to memorize
- Antiepileptic drug (AED) nonadherence (very common)
- Alcohol withdrawal (typically 6–48 hours after last drink)
- Hypoglycemia
- Hyponatremia (also other electrolyte derangements: , )
- Stroke/ICH, CNS infection, tumor, trauma
- Toxin/drug-induced
- Isoniazid (INH) → seizures from ↓ GABA synthesis (↓ pyridoxine)
- Antidote: pyridoxine (vitamin B6)
- Bupropion, tramadol, cocaine/amphetamines
- Isoniazid (INH) → seizures from ↓ GABA synthesis (↓ pyridoxine)
- Eclampsia (pregnancy + seizures) → treat with magnesium sulfate
“Don’t-miss” Step associations
- Febrile seizures (kids) are usually benign, but prolonged febrile seizure can become SE.
- HSV encephalitis (temporal lobe) can present with seizures/AMS → treat with acyclovir.
Clinical Presentation: Convulsive vs Nonconvulsive
Convulsive status epilepticus (CSE)
- Overt tonic-clonic activity > 5 minutes
- May start as focal seizure with secondary generalization
- Postictal state may be absent because they never return to baseline
Complications to anticipate
- Hypoxia, aspiration
- Hyperthermia
- Rhabdomyolysis → ↑ CK, AKI, hyperkalemia
- Lactic acidosis
Nonconvulsive status epilepticus (NCSE)
Often tested as:
- Persistent altered mental status, confusion, agitation, subtle twitching (eyelids, facial), nystagmus, automatisms
- Post-convulsive state that doesn’t clear (patient remains “postictal” too long)
Exam clue: “Still not waking up 30–60 minutes after a seizure + vitals stabilized” → get EEG.
Diagnosis: What to Do While Treating
Status epilepticus is a clinical diagnosis, and treatment should not wait for confirmatory tests.
Immediate bedside priorities (ABCs)
- Airway (consider early intubation if ongoing convulsions or depressed mental status)
- Oxygen, suction, monitoring
- IV access (often 2 lines)
- Check point-of-care glucose (give dextrose if low; consider thiamine in malnourished/alcohol use)
Key labs and tests
| Test | Why it matters |
|---|---|
| POC glucose | Correct hypoglycemia immediately |
| CMP (Na, Ca, Mg), BUN/Cr | Electrolyte triggers; renal function for dosing |
| CBC, cultures if febrile | Infection/meningitis/encephalitis |
| AED levels (if applicable) | Nonadherence or subtherapeutic levels |
| Tox screen | Stimulants, INH, etc. |
| ABG/VBG, lactate | Acidosis severity |
| CK, urinalysis | Rhabdomyolysis |
| ECG | QRS/QT issues; tox clues |
| EEG | Essential for NCSE and refractory cases |
| Head CT (noncontrast) | Rule out bleed/mass if new focal deficits, trauma, first seizure, immunocompromised |
Lumbar puncture: if you suspect CNS infection and imaging doesn’t contraindicate it—but don’t delay seizure control.
Treatment Algorithm (The USMLE-Friendly Flow)
This is the money section. The most testable pattern is:
Benzodiazepine → longer-acting AED → refractory anesthesia + ICU + EEG.
Step 0: Stabilize + “reversible causes”
- ABCs, oxygen, cardiac monitor
- Glucose: give dextrose if low
- Consider thiamine before glucose in malnourished/alcohol use (classic Step association)
- Correct electrolytes as needed
Step 1 (First-line): Benzodiazepine (fastest way to stop seizures)
Preferred options
- Lorazepam IV (often preferred due to longer CNS duration)
- Diazepam IV (rapid onset, shorter CNS duration)
- Midazolam IM/IN if no IV access
Mechanism (First Aid cross-reference)
Benzos increase frequency of GABA-A opening → ↑ influx → neuronal inhibition.
High-yield nuance: Effectiveness declines as SE persists due to GABA-A receptor internalization.
Step 2 (Second-line): “Load” a longer-acting antiseizure med
Common choices:
- Fosphenytoin/phenytoin
- Valproate
- Levetiracetam
Fosphenytoin/Phenytoin (classic board favorite)
- MOA: blocks voltage-gated Na+ channels (stabilizes inactivated state)
- Key adverse effects (Phenytoin — First Aid staples):
- Nystagmus, ataxia, diplopia
- Gingival hyperplasia
- Hirsutism
- Megaloblastic anemia (↓ folate)
- Osteopenia (CYP induction → ↑ vitamin D metabolism)
- Teratogenic (fetal hydantoin)
- SJS/TEN risk (esp. certain HLA types)
- Fosphenytoin: fewer infusion reactions than phenytoin
Valproate (great option in some patients)
- MOA: ↑ GABA (inhibits degradation), blocks Na+ channels
- AEs: hepatotoxicity, pancreatitis, neural tube defects, thrombocytopenia
Levetiracetam
- MOA: SV2A modulation (synaptic vesicle protein)
- AEs: mood changes/irritability (generally well tolerated)
Step pattern: If benzo stops the convulsions, you still need a loading AED to prevent recurrence.
Step 3: Refractory Status Epilepticus (ICU + continuous EEG)
Refractory SE = persists despite benzo + second-line AED.
Treatment:
- Intubate + continuous EEG
- Continuous infusion anesthetic (typical options):
- Midazolam
- Propofol
- Barbiturate (pentobarbital)
Propofol warning (Step 2-style ICU pearl):
- Propofol infusion syndrome (rare but deadly): metabolic acidosis, rhabdo, cardiac failure.
Nonconvulsive status often lives here: patient looks “quiet,” but EEG shows persistent seizure activity → treat like SE.
Special Scenarios You Should Recognize
INH-induced seizures
- Cause: ↓ pyridoxine → ↓ GABA
- Treat: benzodiazepines + pyridoxine (B6)
Eclampsia
- Treat seizures: magnesium sulfate
- Definitive: delivery
- Beware: magnesium toxicity (loss of DTRs, respiratory depression)
Alcohol withdrawal seizures
- First-line: benzodiazepines
- Prevent: thiamine, fluids, treat autonomic instability; consider ICU if severe.
High-Yield “How They’ll Ask It” Vignettes
1) “5 minutes is the cutoff”
A patient has generalized tonic-clonic movements for 6 minutes → treat as SE with IV benzo immediately.
2) “Postictal too long” = consider NCSE
Patient had a convulsive seizure, now no longer convulsing but remains unresponsive 45 minutes later → EEG and treat for NCSE if confirmed.
3) “Benzo then phenytoin”
They’ll often ask: after lorazepam, what next?
Answer: fosphenytoin/phenytoin (or valproate/levetiracetam).
4) “Prevent complications”
Long convulsive seizure + dark urine + very high CK → rhabdo → aggressive IV fluids, monitor electrolytes.
First Aid Cross-References (Where This Lives in FA)
Use these as anchor points when you review:
- GABA-A pharmacology: benzodiazepines (↑ frequency), barbiturates (↑ duration)
- Phenytoin: Na+ channel blockade + classic toxicity list (nystagmus, ataxia, gingival hyperplasia, hirsutism, megaloblastic anemia, osteopenia, teratogen, SJS)
- Valproate: hepatotoxicity, pancreatitis, neural tube defects
- INH toxicity: seizures treated with pyridoxine
- Alcohol withdrawal: benzos
- Eclampsia: magnesium sulfate
(Edition page numbers vary, so use the index for: “status epilepticus,” “phenytoin,” “benzodiazepines,” “isoniazid,” “eclampsia.”)
Rapid-Fire Review (Exam-Day Bullets)
- SE = min convulsive seizure or recurrent seizures without regaining baseline.
- First-line: benzodiazepine (lorazepam IV; midazolam IM if no access).
- Second-line: load fosphenytoin/phenytoin, valproate, or levetiracetam.
- If ongoing: refractory SE → ICU, intubate, continuous EEG, anesthesia (propofol/midazolam/pentobarbital).
- NCSE = altered mental status + seizure on EEG—don’t miss it.
- Correct glucose/electrolytes, consider toxins (INH → B6).
- Complications: hypoxia, aspiration, acidosis, hyperthermia, rhabdo.